NHT
LLY icon

New Hampshire Trust’s Eli Lilly LLY Stock Holding History

New Hampshire Trust’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12M Buy
933
+99
+12% +$101K 0.21% 77
2026
Q1 		$767K Sell
834
-112
-12% -$114K 0.15% 89
2025
Q4 		$1.02M Buy
946
+211
+29% +$202K 0.2% 81
2025
Q3 		$561K Buy
735
+43
+6% +$32K 0.11% 110
2025
Q2 		$539K Buy
692
+24
+4% +$18.6K 0.11% 111
2025
Q1 		$552K Sell
668
-32
-5% -$26.6K 0.13% 104
2024
Q4 		$540K Sell
700
-4
-0.6% -$3.31K 0.11% 108
2024
Q3 		$624K Sell
704
-5
-0.7% -$4.5K 0.13% 99
2024
Q2 		$642K Sell
709
-5
-0.7% -$4K 0.15% 95
2024
Q1 		$555K Buy
714
+28
+4% +$19.9K 0.13% 106
2023
Q4 		$400K Buy
686
+177
+35% +$103K 0.1% 124
2023
Q3 		$273K Sell
509
-61
-11% -$31.4K 0.07% 139
2023
Q2 		$267K Buy
570
+6
+1% +$2.52K 0.07% 141
2023
Q1 		$194K Sell
564
-76
-12% -$25.6K 0.05% 165
2022
Q4 		$234K Buy
+640
New +$227K 0.06% 155

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

New Hampshire Trust's LLY Position: Q2 2026 in Review

New Hampshire Trust increased its Eli Lilly (LLY) stake by 12% in Q2 2026, buying an estimated $101K and bringing the position to 933 shares worth $1.12M. The position accounts for 0.21% of the portfolio, ranked #77.

New Hampshire Trust first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • New Hampshire Trust held 933 shares of Eli Lilly worth $1.12M as of Q2 2026.
  • New Hampshire Trust bought 99 Eli Lilly shares in Q2 2026, an estimated $101K.
  • Eli Lilly made up 0.21% of New Hampshire Trust's portfolio in Q2 2026, its #77 holding.
  • New Hampshire Trust first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on New Hampshire Trust's 13F filing for Q2 2026, filed 27 Jul 2026.